Clinical Trial Update: The Efficacy and Tolerance of Tacrolimus Sustained-release Capsules on Refractory Nephrotic Syndrome (RNS) [Phase 3]

View source ↗

Summary

Phase 3 trial assessing the efficacy and tolerability of Tacrolimus sustained-release capsules in patients with refractory nephrotic syndrome.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nephrotic Syndrome

Drugs mentioned

• Tacrolimus Sustained-release Capsule (Tacrolimus)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nephrotic Syndrome | Phase 3 | Status: COMPLETED